dronabinol has been researched along with n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brune, K; Hinz, B; Ramer, R; Rösch, S | 1 |
| Bhattacharjee, H; Kiani, MF; Kosanke, S; Moore, BM; Nadipuram, A | 1 |
| Abazyan, B; Hasegawa, Y; Jouroukhin, Y; Kamiya, A; Pevsner, J; Pletnikov, MV; Saito, A; Shevelkin, AV; Zhu, X | 1 |
3 other study(ies) available for dronabinol and n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide
| Article | Year |
|---|---|
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells.
Topics: Arachidonic Acids; Cannabinoids; Cells, Cultured; Cilia; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Dronabinol; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Humans; Matrix Metalloproteinases; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Phosphorylation; RNA, Messenger; Sulfonamides; Tissue Inhibitor of Metalloproteinase-1 | 2006 |
Low-volume binary drug therapy for the treatment of hypovolemia.
Topics: Animals; Cannabinoid Receptor Agonists; Cyclooxygenase 2 Inhibitors; Dronabinol; Drug Combinations; Interleukin-10; Male; Mice; Mice, Inbred C57BL; Muscle, Striated; Nitrobenzenes; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Shock; Sulfonamides | 2011 |
Adolescent Δ
Topics: Age Factors; Animals; Astrocytes; CA3 Region, Hippocampal; Cyclooxygenase 2; Dronabinol; Female; Gene Knockdown Techniques; Hippocampus; Male; Memory; Mice; Mice, Transgenic; Nerve Tissue Proteins; NF-kappa B; Nitrobenzenes; Parvalbumins; Presynaptic Terminals; Pyramidal Cells; Recognition, Psychology; Signal Transduction; Sulfonamides | 2019 |